Endocannabinoid System Clinical Research: Topical Cannabis Balm Efficacy in AIMSS Treatment
This study evaluates topical cannabis balm efficacy for managing AIMSS in breast cancer patients. The trial shows high tolerability and feasibility of cannabinoid balms. Results suggest potential benefits for aromatase inhibitor-related joint pain.
Topical Cannabis for AIMSS: Medical Cannabis Evidence-Based Care
Topical cannabinoids for AIMSS offer a promising approach to managing joint pain and stiffness caused by aromatase inhibitor therapy. Clinical trials show these balms are generally well-tolerated and feasible for use. This evidence-based care option may…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trial
This cannabinoid clinical trial evaluated topical cannabis for AIMSS, focusing on feasibility and tolerability in managing joint pain from aromatase inhibitors. The study showed topical cannabis was generally well tolerated with no serious adverse…